Related Experiment Video

Updated: Jun 13, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Subclinical hypothyroidism in childhood

M J O'Grady1, D Cody

  • 1Department of Endocrinology and Diabetes, Our Ladys Childrens Hospital, Crumlin, Dublin, Ireland.

Archives of Disease in Childhood
|April 24, 2010
PubMed

Insights

Subclinical hypothyroidism (SH) involves elevated thyroid stimulating hormone (TSH) with normal thyroid hormones. This review examines evidence for investigating and treating SH in children, as consensus is lacking.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neonatology

Background:

  • Subclinical hypothyroidism (SH) is characterized by elevated thyroid stimulating hormone (TSH) and normal thyroxine (T4)/triiodothyronine (T3) levels.
  • SH is common in neonatology and pediatric practice, but its clinical significance remains debated.
  • There is a lack of consensus regarding the investigation and treatment thresholds for pediatric SH.

Purpose of the Study:

  • To review current evidence on the investigation and management of subclinical hypothyroidism in children.
  • To explore treatment outcomes and consensus guidelines for childhood SH.
  • To provide a comprehensive overview of the diagnostic and therapeutic challenges in pediatric SH.

Main Methods:

  • Literature review of existing studies on subclinical hypothyroidism in pediatric populations.
  • Analysis of evidence concerning diagnostic criteria and treatment protocols for SH.
  • Examination of reported outcomes in treated and untreated children with SH.

Main Results:

  • Evidence regarding the investigation and treatment of childhood SH is varied and lacks broad consensus.
  • Specific TSH cut-off levels for intervention in pediatric SH are not universally agreed upon.
  • Outcomes data for childhood SH are limited, contributing to the ongoing debate.

Conclusions:

  • Further research is needed to establish clear guidelines for the investigation and treatment of SH in children.
  • A consensus on management strategies for pediatric subclinical hypothyroidism is essential.
  • Understanding the long-term outcomes of SH in childhood is crucial for clinical decision-making.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...